Joel S. Hirschhorn – April 19, 2022
The COVID pandemic is far from over. It has now morphed into long COVID with millions of people suffering.
Sometimes what seems like a miraculous new medical remedy comes along. And without government involvement. In those cases, millions of long COVID sufferers have an opportunity to use a new remedy and judge whether it’s safe and truly effective. In contrast, the medical establishment and specialists work at fixing the many diverse symptoms and illnesses of long COVID patients.
So, what are long COVID sufferers to do? There are no easy choices.
This analysis and discussion aim to help them make informed and difficult decisions.
Over the past year or so a great many victims of long COVID believe they have found a medical cure. There is a lot of skepticism among medical professionals treating long COVID patients, often at specialized hospital centers – and that skepticism is warranted.
A recent article is titled, “66 hospitals, health systems that have launched post-COVID-19 clinics.” It notes: “Many hospitals and health systems have created COVID-19 recovery programs, or post-COVID clinics, to support patients who experience lingering symptoms weeks or months after being cleared of the illness – a population now widely known as COVID-19 long-haulers. Most COVID-19 recovery programs currently involve an initial evaluation and, as needed, referrals to a network of specialists such as pulmonologists, cardiologists and neurologists, among others.”
Several excellent, detailed investigative reports examine the system that the impressively credentialed Dr. Bruce Patterson and his company IncellDX have created. His treatment has also built a large following on social media sites. No surprise. COVID long-haulers want to restore their quality of life.
One big problem in fairly examining the new revolutionary medical solution is the vast array of long COVD symptoms, as shown in the figure below. Physicians face the daunting challenge of addressing many symptoms successfully to fully satisfy patients.